14556-full
mislissa1029
Sex: F
Data Quality: 2 stars
MS: 10 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Moderate
Cognition: moderate
Vision: moderate
Speech: mild
Swallowing: mild
Upper limb: moderate
Walking: moderate
mislissa1029
Female, 31 years
Winter Haven, FL
Primary Condition
MS and 2 more ▼
Type
Relapsing-Remitting
First symptom
Diagnosis
See more
  1. 14556-thumb
    mislissa1029
    Sex: F
    Data Quality: 2 stars
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    I am: n
    I have:
    MS

    Urinary Incontinence

    • First symptom: ?
    • Diagnosis:
    updated the condition Urinary Incontinence Apr 10, 2013
  2. 14556-thumb
    mislissa1029
    Sex: F
    Data Quality: 2 stars
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    I am: n
    I have:
    MS

    ADD (Attention Deficit Disorder)

    • First symptom: ?
    • Diagnosis: ?
    updated the condition ADD (Attention Deficit Disorder) Apr 10, 2013
  3. 14556-thumb
    mislissa1029
    Sex: F
    Data Quality: 2 stars
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    I am: n
    I have:
    MS

    MS (Multiple Sclerosis)

    • First symptom:
    • Diagnosis:
    updated the condition MS (Multiple Sclerosis) Apr 10, 2013
  4. 14556-thumb
    mislissa1029
    Sex: F
    Data Quality: 2 stars
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    I am: n
    I have:
    MS

    Fingolimod

      • Started: Oct 25, 2011
      • Current Dosage: 0.5 mg daily
    • Purpose: MS
    updated the treatment Fingolimod Mar 22, 2012
  5. 14556-thumb
    mislissa1029
    Sex: F
    Data Quality: 2 stars
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    I am: n
    I have:
    MS

    Fingolimod

      • Started: Oct 25, 2011
      • Current Dosage: 0.5 mg daily
    • Purpose: MS
    updated the treatment Fingolimod Mar 22, 2012
  6. 14556-thumb
    mislissa1029
    Sex: F
    Data Quality: 2 stars
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    I am: n
    I have:
    MS

    Tysabri Treatment Evaluation

    • Perceived effectiveness for MS (Multiple Sclerosis): Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major
    • Side Effects: MildMildMildMildMild
    • Adherence: UsuallyUsuallyUsuallyUsuallyUsually
    • Burden: VeryVeryVeryVeryVery
    Cost
    < $25 monthly
    added a treatment evaluation for Tysabri from Apr 1, 2011 Oct 21, 2011